DESIGNED TO
PREVENT MIGRAINE^1

AQUIPTA is a simple once-daily tablet that works fast
to prevent migraine.1,2

^In 3-month clinical studies, AQUIPTA significantly reduced monthly migraine days.1

In a clinical study, 87.7% of patients who received AQUIPTA 60 mg did not have a migraine on day 1 after first dose compared to 74.8% on placebo.2

HOW TO ACCESS

To access AQUIPTA, your General Practitioner (GP) or Specialist will need to prescribe the treatment for you.

AQUIPTA is a prescription medicine that is not funded. It is available for private purchase, which means you will need to pay for this medicine.

An access program has been established with Airport Oaks Pharmacy to make AQUIPTA available at a discounted price to patients. Airport Oaks Pharmacy can courier AQUIPTA anywhere in New Zealand.


A diagram of the access program is shown below.

Further details, including price, can be found in the “How to Access” section in the Patient Booklet.

STEP 1: PATIENT VISITS GP OR SPECIALIST

  1. GP or Specialist determines if patient is suitable for AQUIPTA.
  2. Patient is willing to pay for private prescription.

STEP 2: PRESCRIPTION SENT TO PHARMACY

To be eligible for the access program with the discounted price, the GP or Specialist will send the e-script to Airport Oaks Pharmacy.

STEP 3: PATIENT RECEIVES MEDICINE

  1. Airport Oaks Pharmacy calls patient to arrange payment.
  2. Patient either collects AQUIPTA from Airport Oaks Pharmacy or Airport Oaks Pharmacy will courier to the chosen address.

The access program may be expanded to other pharmacies, subject to them being able to meet certain criteria and signing up to the relevant terms and conditions of the access program. If a pharmacy wants to enquire about the access program, they should contact AbbVie on 0800 900 030.

Outside of the access program, AQUIPTA is also available for private purchase with prescription from any other pharmacy. It is suggested you check the price with the selected pharmacy as prices may vary.


Please refer to the AQUIPTA Patient Booklet for further details on how to access AQUIPTA and price information.


References: 1. AQUIPTA® (atogepant) Data Sheet. 2. Schwedt TJ, et al. Cephalalgia. 2022;42(1):3-11.

NZ-AQP-240019. TAPS BG4309. ABB2630. Date prepared September 2024.